[ Skip to Main Content ]
COVID-19: How We’re Responding

Our Work

Register for our @USAID-funded @fistulacare Plus project's webinar on Sep 30th at 8:30 AM EDT!
Panelists from @PanziUSA & Mama (@jmckinneypt @lauraekeyser) will discuss the impact of physical rehabilitation in #fistula & maternity care.

#FistulaCareOnline
http://bit.ly/PT-fistula

Only 30% of countries are reporting sex-disaggregated data on cases and deaths during #COVID19. We must prioritize collecting comprehensive data to fully understand and respond to the dynamics of this crisis.

Read more in @Devex: https://bit.ly/3mnjNsu

As part of @womeninGH, @WagnerFound & @ForeignPolicy's #WGHSecuritySummit, we've joined a diverse group of governments & organizations in making commitments to work towards a gender-equal, post-COVID world.

See all the commitments here: https://lnkd.in/eUSBMqR

#COVID5050 #UNGA

"While women provide $3 trillion of care annually, half of that is unpaid...We're asking for a new social contract for women in health that recognizes & values their contribution.” -@RoopaDhatt

Read more in @womeninGH’s brief on health security & women: https://bit.ly/3iPi6BT.

Dr. Ajay Khera, our Country Representative for India, emphasized the importance of private sector engagement in achieving universal health coverage & strengthening health outcomes in #India at @SHOPSPlus' recent webinar. View his speech at 16 min here: https://bit.ly/2H57Yao

Register today! Our @USAID-funded @fistulacare Plus project, with partners @PanziUSA & Mama (@jmckinneypt @lauraekeyser), are hosting a webinar on integrating physical therapy into fistula & maternity care on Sep 30th at 8:30 AM EDT.

#FistulaCareOnline
http://bit.ly/PT-fistula

New Report: COVID-19 Global Health Security Depends on Women: Rebalancing the unequal social contract for women

Check it out to learn what you can do.
https://covid5050.org/report/
#COVID5050 #WGHSecuritySummit #UNGA #COVID19 #GenderEquality #SDG3 #SDG5 #GlobalGoals #SDGs

Depuis quelques jours se tient l'atelier d’élaboration du rapport de l’évaluation du Plan d’Action National Budgétisé Planification Familiale (PANBPF 2016 – 2020) avec la présence et l'appuie financier de @EngenderHealth et ses PTF.
@SOROAboudouN @nenef

And that's a wrap on #WGHSecuritySummit at the #UNGA. Thank you to all of our speakers and attendees!

What's next? ➡️➡️ putting our words into action!

Learn more about the pledges that came in from global institutions and governments: https://bit.ly/32D8PXZ

We've committed to ensure fair representation of women in leadership, publish gender pay gap data and collect sex- & age-disaggregated data as part of @womeninGH, @WagnerFound & @ForeignPolicy's #WGHSecuritySummit: https://bit.ly/2HaAuYd #COVID5050

Load More...

Eclampsia and Pre-Eclampsia

Giving birth should be a time for celebration, but for more than half a million women each year—one every 90 seconds—pregnancy and childbirth end in death and mourning. Ninety-nine percent of these deaths occur in developing countries, and nearly all are preventable.

One of the leading causes of maternal death is pre-eclampsia—the rapid elevation of blood pressure during pregnancy—which, if untreated, can lead to seizures (eclampsia), kidney and liver damage, and ultimately, death. Eclampsia and severe pre-eclampsia claim the lives of an estimated 63,000 women each year, as well as the lives of many of their babies.  

A Ready Solution
The World Health Organization recognizes and recommends injectable magnesium sulfate—also known as Epsom salts—as the safest, most effective, and lowest-cost medication for treating pre-eclampsia and eclampsia. Magnesium sulfate is the standard treatment for these conditions in the developed world and has been for 20 years. Less-effective and riskier medications (such as diazepam and phenytoin), however, are still widely used in developing countries—if any treatment is available at all.

 

OUR COMMITMENT
We commit to reducing maternal mortality with magnesium sulfate in India, Mexico, and Nigeria. Through training, advocacy, and education, we will increase access to the lifesaving treatment for pre-eclampsia and eclampsia, leading causes of maternal mortality.

 

 

Clinton Global Initiative Commitment
This disparity must end. EngenderHealth, the University of Oxford, and the John D. & Catherine T. MacArthur Foundation are making a joint commitment as part of the Clinton Global Initiative to expand access to magnesium sulfate by:

  • Training health professionals through web-based interactive programs on when and how to administer magnesium sulfate
  • Advocating for magnesium sulfate to be part of every developing country’s list of essential drugs
  • Helping develop and/or reinforce national protocols mandating magnesium sulfate as the preferred treatment for pre-eclampsia and eclampsia
  • Ensuring the availability of magnesium sulfate in hospitals

Call to Action
In 2007, EngenderHealth and the University of Oxford brought together leading scientists, advocates, researchers, and representatives of the WHO, UNICEF, United Nations agencies, and national ministries of health from around the world to identify barriers to the availability and use of magnesium sulfate to treat pre-eclampsia and eclampsia. This historic gathering of global public health experts identified the primary barriers to be a lack of national guidelines, a shortage of educated and trained health care professionals, and scarce supplies of magnesium sulfate.

Based on these conclusions, EngenderHealth and the University of Oxford developed a “Call to Action” and report that called on policy makers and ministers of health to make pre-eclampsia and eclampsia a higher priority and to set national guidelines for treatment and care based on WHO guidelines. Decision makers and international and national health organizations and agencies were also urged to help make magnesium sulfate more available and affordable.

The full report, Balancing the Scales: Expanding Treatment for Pregnant Women with Life-Threatening Hypertensive Conditions in Developing Countries, is available for download (PDF, 316KB), as is the International Call to Action (PDF, 27KB).

Share this page: